Call: 1-800-887-8100

 

New here?
Please register Already a member?
Sign in now

 
About COPAXONE(R) Taking COPAXONE(R) Your Immune System About Multiple Sclerosis About Shared Solutions(R) Available Therapies
  Share Print

About COPAXONE®

Why is COPAXONE® a smart choice for so many people?


If you add up the number of years that people with relapsing-remitting multiple sclerosis (RRMS) have taken COPAXONE®, it equals over 1 million patient-years of experience worldwide.1

3-1-0_1million_mark.jpgWhen you take COPAXONE®, you have the confidence of knowing what to expect. Along with the value of an established track record, you can feel confident that COPAXONE® works with the immune system. COPAXONE® is thought to stimulate the development of beneficial, protective T cells in your central nervous system (CNS). In treating MS, this may help restore balance in your immune system.2,3

  • Proven effective for the long term with 19 years of clinical experience1,4
  • Believed to work with your immune system
    to fight RRMS2,3

COPAXONE® works with the immune system


  • COPAXONE® has a unique way of acting in the body
  • In treating MS, this may help restore balance in your immune system6
  • COPAXONE® is made from synthetic proteins that contain a blend of 4 naturally occurring amino acids6
  • There is no evidence that COPAXONE® reduces the body’s normal immune response, but this has not been systematically evaluated6

Ask your doctor why COPAXONE® is a smart choice for you.


Video Title Long-Term Efficacy and Safety
Dr. Thrower  
Current rating: 3.3 (27 ratings)
References:
1. Data on file. Teva Neuroscience, Inc. 2. Weber MS, Hohlfeld R, Zamvil SS. Neurotherapeutics. 2007;4(4):647-653. 3. Miller A, Shapiro S, Gershtein R, et al. J Neuroimmunol. 1998;92(1-2):113-121. 4. Ford C, Goodman AD, Johnson K, et al. Mult Scler. 2010;16(3):342-350. 5. Comi G, Martinelli V, Rodegher M, et al; for the PreCISe study group. Lancet. 2009;374(9700):1503-1511. 6. COPAXONE® (glatiramer acetate injection) prescribing information. Teva Neuroscience, Inc. 7. Avonex® (interferon beta-1a) prescribing information. Biogen Idec Inc. 8. Betaseron® (interferon beta-1b) prescribing information. Bayer HealthCare Pharmaceuticals Inc. 9. Extavia® (interferon beta-1b) prescribing information. Novartis Pharmaceuticals Corporation. 10. Rebif® (interferon beta-1a) prescribing information. EMD Serono, Inc.
COP100006202/102144
  • COPAXONE® (glatiramer acetate injection) is indicated for the reduction of the frequency of relapses in relapsing-remitting multiple sclerosis, including patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

Important Safety Information About COPAXONE®

  • The most common side effects of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These reactions are usually mild and seldom require professional treatment. Be sure to tell your doctor about any side effects.

    Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and go away by themselves without further problems.

    A permanent indentation under the skin at the injection site may occur, due to a local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.

    After you inject COPAXONE®, call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, severe pain at the injection site or other uncomfortable changes in your general health. Do not give yourself any more injections until your doctor tells you to begin again.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

#1 Prescribed RRMS therapy in the US*

Suggested articles

Benefits & Insurance Assistance

COPAXONE Co-pay Solutions™

Therapy and Immune Health

10 Tips for CarePartners

Choosing a Therapy

Your MS Online Planner

My recent articles

Taking COPAXONE®

Daily Life

COPAXONE® FAQs

Helpful Links
For frequently asked questions concerning COPAXONE®,
click here.
What it means to have an immune smart therapy.
EileenWhen I was first diagnosed, I never thought I’d be living the life I’m living today. With COPAXONE®, I get long-term effectiveness and a safe and well-tolerated therapy that’s been proven for over a decade.†

—Eileen K., on COPAXONE® for RRMS since 1998

Individual results may vary.

 

†Ford CC, Johnson KP, Lisak RP, et al. Mult Scler. 2006;12:309-32.
master_PDF.png  Download Adobe Acrobat
*IMS Health National Prescription Audit, May 2011. Data is proprietary to IMS Health.
 

COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered trademark of Teva Neuroscience, Inc. autoject® 2 for glass syringe is a registered trademark of Owen Mumford, Ltd. COPAXONE CO-PAY SOLUTIONS™ is a trademark of Teva Pharmaceutical Industries Ltd. © 2011, Teva Neuroscience, Inc. All Rights Reserved. This site is intended for US residents only.

The brands listed are the trademarks and registered trademarks of their respective owners.